Vialle R, de Paiva Lopes K, Li Y, Ng B, Schneider J, Buchman A
Genome Med. 2025; 17(1):20.
PMID: 40038788
PMC: 11881306.
DOI: 10.1186/s13073-025-01444-6.
Szegvari E, Holec S, Woerman A
J Neurochem. 2025; 169(3):e70021.
PMID: 40026260
PMC: 11874209.
DOI: 10.1111/jnc.70021.
Qiu T, Li J, Guo Y, Jiang L, Tang J
J Transl Med. 2025; 23(1):221.
PMID: 39987107
PMC: 11846410.
DOI: 10.1186/s12967-025-06213-y.
Karagas N, Young J, Blue E, Jayadev S
Neurol Genet. 2025; 11(1):e200224.
PMID: 39885961
PMC: 11781270.
DOI: 10.1212/NXG.0000000000200224.
Hardy J, Escott-Price V
Mol Psychiatry. 2025; .
PMID: 39880902
DOI: 10.1038/s41380-025-02911-7.
A de novo, mosaic and complex chromosome 21 rearrangement causes APP triplication and familial autosomal dominant early onset Alzheimer disease.
Ehn E, Eisfeldt J, Laffita-Mesa J, Thonberg H, Schoumans J, Portaankorva A
Sci Rep. 2025; 15(1):2912.
PMID: 39849058
PMC: 11759332.
DOI: 10.1038/s41598-025-86645-0.
Epigenetics in Neurodegenerative Diseases.
van Zundert B, Montecino M
Subcell Biochem. 2025; 108():73-109.
PMID: 39820861
DOI: 10.1007/978-3-031-75980-2_3.
On the Therapeutic Use of Monoclonal Antibodies Against Amyloid Plaques in Older Adults with Down Syndrome: A Narrative Review and Perspective.
Costa A
Brain Sci. 2024; 14(11).
PMID: 39595846
PMC: 11591668.
DOI: 10.3390/brainsci14111084.
Input of exome sequencing in early-onset cerebral amyloid angiopathy.
Grangeon L, Charbonnier C, Rousseau S, Richard A, Quenez O, Zarea A
Alzheimers Dement (Amst). 2024; 16(4):e70027.
PMID: 39583652
PMC: 11585166.
DOI: 10.1002/dad2.70027.
The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence.
Aisen P, Bateman R, Crowther D, Cummings J, Dwyer J, Iwatsubo T
Alzheimers Dement. 2024; 21(1):e14342.
PMID: 39535341
PMC: 11772734.
DOI: 10.1002/alz.14342.
FindCSV: a long-read based method for detecting complex structural variations.
Zheng Y, Shang X
BMC Bioinformatics. 2024; 25(1):315.
PMID: 39342151
PMC: 11439270.
DOI: 10.1186/s12859-024-05937-w.
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
Liu E, Zhang Y, Wang J
Transl Neurodegener. 2024; 13(1):45.
PMID: 39232848
PMC: 11373277.
DOI: 10.1186/s40035-024-00432-x.
Structural variants linked to Alzheimer's Disease and other common age-related clinical and neuropathologic traits.
Vialle R, de Paiva Lopes K, Li Y, Ng B, Schneider J, Buchman A
medRxiv. 2024; .
PMID: 39185527
PMC: 11343262.
DOI: 10.1101/2024.08.12.24311887.
Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.
Kasri A, Camporesi E, Gkanatsiou E, Boluda S, Brinkmalm G, Stimmer L
Acta Neuropathol. 2024; 148(1):8.
PMID: 39026031
PMC: 11258176.
DOI: 10.1007/s00401-024-02756-4.
SVDF: enhancing structural variation detect from long-read sequencing via automatic filtering strategies.
Hu H, Gao R, Gao W, Gao B, Jiang Z, Zhou M
Brief Bioinform. 2024; 25(4).
PMID: 38980375
PMC: 11232458.
DOI: 10.1093/bib/bbae336.
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease.
Galasko D, Farlow M, Lucey B, Honig L, Elbert D, Bateman R
Alzheimers Res Ther. 2024; 16(1):151.
PMID: 38970127
PMC: 11225352.
DOI: 10.1186/s13195-024-01490-z.
LoRA-TV: read depth profile-based clustering of tumor cells in single-cell sequencing.
Duan J, Zhao X, Wu X
Brief Bioinform. 2024; 25(4).
PMID: 38877886
PMC: 11179121.
DOI: 10.1093/bib/bbae277.
Amyloid β accelerates age-related proteome-wide protein insolubility.
Anderton E, Chamoli M, Bhaumik D, King C, Xie X, Foulger A
Geroscience. 2024; 46(5):4585-4602.
PMID: 38753231
PMC: 11335993.
DOI: 10.1007/s11357-024-01169-1.
The broken Alzheimer's disease genome.
Roque C, Phatnani H, Hengst U
Cell Genom. 2024; 4(5):100555.
PMID: 38697121
PMC: 11099344.
DOI: 10.1016/j.xgen.2024.100555.
Nucleoside Reverse Transcriptase Inhibitor Exposure Is Associated with Lower Alzheimer's Disease Risk: A Retrospective Cohort Proof-of-Concept Study.
Chow T, Raupp M, Reynolds M, Li S, Kaeser G, Chun J
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675371
PMC: 11053431.
DOI: 10.3390/ph17040408.